Delayed Nausea/Emesis
Emetic risk category Phase Guideline recommendations MASCC/EMSO NCCN ASCO I. High (>90 %) risk Acute 5-HT3RA (palonosetron) + DMZ + APR (or FOS) 5-HT3RAa + DMZ (12 mg) + APR (125 mg) 5-HT3RA (palonosetron) + DMZ + APR Delayed DMZ + APR DMZ (8…